INVO Bioscience (IVOB.OB) Commences In-Vitro Fertilization Trial in Brazil
INVO Bioscience Inc., a medical device company focused on treatment options for patients diagnosed with infertility, today announced it has started a 40 patient clinical trial in Rio de Janeiro, Brazil, to establish the safety, efficacy and comparative in-vitro fertilization (IVF) measures of the INVOcell device. The design for the trial is awaiting approval by the Federal Ethics Committee in Brazil, at which time, the results from the completed clinical study will be submitted to the National Health Surveillance Agency (ANVISA), allowing for the registration and approval for the sale of the INVOcell device in Brazil. "INVO Bioscience continues to…